Publications by authors named "Kenneth Yu"

Claim this Profile
P
PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic Cancer.
Jennifer J Knox, Grainne O'Kane, Daniel King, Daniel Laheru, Amber N Habowski, Kenneth Yu

J Clin Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic Cancer.
Jennifer J Knox, Grainne O'Kane, Daniel King, Daniel Laheru, Amber N Habowski, Kenneth Yu

J Clin Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical utility and tissue concordance of circulating tumor DNA in pancreatic ductal adenocarcinoma.
Fergus Keane, Lily V Saadat, Catherine A O'Connor, Joanne F Chou, Anita S Bowman, Kenneth H Yu

J Natl Cancer Inst· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab and Olaparib (POLAR) Maintenance Therapy in Metastatic Pancreatic Cancer With or Without Homologous Repair Deficiency: A Biomarker Selected Phase II Trial.
Wungki Park, Catherine O'Connor, Joanne Chou, Marc Hilmi, Zeynep Tarcan, Kenneth Yu, Tae-Hyung Kim

Res Sq· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonoperative Management of Technically Resectable Pancreatic Cancer With Ablative Radiation Therapy.
Marsha Reyngold, Joshua D Schoenfeld, Eileen M O'Reilly, Anna M Varghese, Charlie White, Kenneth H Yu

JAMA Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant modified FOLFIRINOX for resected pancreatic adenocarcinoma: clinical insights and genomic features from a large contemporary cohort.
Fergus Keane, Catherine O'Connor, Drew Moss, Joanne F Chou, Maria A Perry, Kenneth H Yu

J Natl Cancer Inst· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aggressive cutaneous squamous cell carcinoma in a patient on Janus-kinase inhibitor therapy.
Ana M Aragon Sierra, Kevin J Donohoe, Daniel J Canaday, Ernest D Gomez, Scharukh M Jalisi, Kenneth K Yu

JAAD Case Rep· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicogenomic landscape of pancreatic adenocarcinoma identifies KRAS mutant dosage as prognostic of overall survival.
Anna M Varghese, Maria A Perry, Joanne F Chou, Subhiksha Nandakumar, Daniel Muldoon, Kenneth H Yu

Nat Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lynch Syndrome and Somatic Mismatch Repair Variants in Pancreas Cancer.
Catherine A O'Connor, Emily Harrold, David Lin, Henry Walch, Andrea Gazzo, Kenneth Yu

JAMA Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Precision medicine for pancreatic cancer: characterizing the clinicogenomic landscape and outcomes of KRAS G12C-mutated disease.
Fergus Keane, Joanne F Chou, Henry Walch, Joshua Schoenfeld, Anupriya Singhal, Kenneth H Yu

J Natl Cancer Inst· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Desmoplasia Is Associated with Decreased Cytotoxic and Helper T Cells and Increased T-Cell Exhaustion in Cutaneous Squamous Cell Carcinoma.
Yuka Hirakawa, Qian Zhan, Sernah Essien, Kenneth K Yu, Fadi Murad

J Invest Dermatol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in Systemic Therapy in Pancreatic Cancer.
Kenneth H Yu

Hematol Oncol Clin North Am· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Morbidity and mortality in patients with stage IV pancreatic adenocarcinoma and acute cholangitis: Outcomes and risk prognostication.
Isha Singh, Joanne F Chou, Marinela Capanu, Jennifer Park, Kenneth H Yu

Pancreatology· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salvage Ablative Radiotherapy for Isolated Local Recurrence of Pancreatic Adenocarcinoma following Definitive Surgery.
Edward Christopher Dee, Victor C Ng, Eileen M O'Reilly, Alice C Wei, Stephanie M Lobaugh, Kenneth H Yu

J Clin Med· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prior irinotecan exposure does not preclude benefit to liposomal irinotecan in patients with metastatic pancreatic ductal adenocarcinoma.
Kenneth H Yu, Paul Cockrum, Andy Surinach, Neil Lamarre, Shu Wang

Cancer Med· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinico-genomic Characterization of ATM and HRD in Pancreas Cancer: Application for Practice.
Wungki Park, Catherine A O'Connor, Chaitanya Bandlamudi, Daniella Forman, Joanne F Chou, Kenneth H Yu

Clin Cancer Res· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methylation Analyses Reveal Promoter Hypermethylation as a Rare Cause of "Second Hit" in Germline BRCA1-Associated Pancreatic Ductal Adenocarcinoma.
Binbin Zheng-Lin, Michael Rainone, Anna M Varghese, Kenneth H Yu, Wungki Park, Ciyu Yang

Mol Diagn Ther· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic ablative radiation for pancreatic cancer on a 1.5 Telsa magnetic resonance-linac system.
Kathryn R Tringale, Neelam Tyagi, Marsha Reyngold, Paul B Romesser, Abraham Wu, Kenneth Yu

Phys Imaging Radiat Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-32 Supports the Survival of Malignant T Cells in Cutaneous T-cell Lymphoma.
Kenneth K Yu, Neal P Smith, Sernah V Essien, Jessica E Teague, Pablo Vieyra-Garcia

J Invest Dermatol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating tumor and invasive cell expression profiling predicts effective therapy in pancreatic cancer.
Kenneth H Yu, Jennifer Park, Avni Mittal, Ghassan K Abou-Alfa, Imane El Dika

Cancer· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concurrent Germline / and Mismatch Repair Mutations in Young-Onset Pancreatic and Colorectal Cancer: The Importance of Comprehensive Germline and Somatic Characterization to Inform Therapeutic Options.
Muhammet Ozer, Megha Ranganathan, Nicolas Lecomte, Juan M Schvartzman, Henry S Walch, Kenneth H Yu

JCO Precis Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
ChemoSensitivity Assay Guided Metronomic Chemotherapy Is Safe and Effective for Treating Advanced Pancreatic Cancer.
William H Isacoff, Brandon Cooper, Andrew Bartlett, Brian McCarthy, Kenneth H Yu

Cancers (Basel)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction FOLFIRINOX for patients with locally unresectable pancreatic ductal adenocarcinoma.
Caitlin A McIntyre, Noah A Cohen, Debra A Goldman, Mithat Gonen, Eran Sadot, Kenneth H Yu

J Surg Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world prognostic factors for survival among treated patients with metastatic pancreatic ductal adenocarcinoma.
Kenneth H Yu, Muhammet Ozer, Paul Cockrum, Andy Surinach, Shu Wang

Cancer Med· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacologically controlling protein-protein interactions through epichaperomes for therapeutic vulnerability in cancer.
Suhasini Joshi, Erica DaGama Gomes, Tai Wang, Adriana Corben, Tony Taldone, Kenneth H Yu

Commun Biol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis